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Introduction: The neutrophil-to-lymphocyte ratio (NLR) is a biological marker that has been shown to be associated
with outcomes in patients with a number of different malignancies. The objective of this study was to assess the
relationship between NLR and mortality in a population of adult critically ill patients.
Methods: We performed an observational cohort study of unselected intensive care unit (ICU) patients based on
records in a large clinical database. We computed individual patient NLR and categorized patients by quartile of
this ratio. The association of NLR quartiles and 28-day mortality was assessed using multivariable logistic regression.
Secondary outcomes included mortality in the ICU, in-hospital mortality and 1-year mortality. An a priori subgroup
analysis of patients with versus without sepsis was performed to assess any differences in the relationship between
the NLR and outcomes in these cohorts.
Results: A total of 5,056 patients were included. Their 28-day mortality rate was 19%. The median age of the cohort
was 65 years, and 47% were female. The median NLR for the entire cohort was 8.9 (interquartile range, 4.99 to 16.21).
Following multivariable adjustments, there was a stepwise increase in mortality with increasing quartiles of NLR (first
quartile: reference category; second quartile odds ratio (OR) = 1.32; 95% confidence interval (CI), 1.03 to 1.71; third
quartile OR = 1.43; 95% CI, 1.12 to 1.83; 4th quartile OR = 1.71; 95% CI, 1.35 to 2.16). A similar stepwise relationship was
identified in the subgroup of patients who presented without sepsis. The NLR was not associated with 28-day mortality
in patients with sepsis. Increasing quartile of NLR was statistically significantly associated with secondary outcome.
Conclusion: The NLR is associated with outcomes in unselected critically ill patients. In patients with sepsis, there
was no statistically significant relationship between NLR and mortality. Further investigation is required to increase
understanding of the pathophysiology of this relationship and to validate these findings with data collected
prospectively.Introduction
More than 5 million patients are admitted to intensive
care units (ICUs) each year in the United States with
survival rates ranging between 10% to 29% depending
on the population studied [1,2]. Systemic inflammation
is an integral part of disease processes in critical illness
and is commonly associated with the sepsis syndrome
[2,3]. Various biomarkers, including acute phase proteins
and cytokines, are frequently used in the ICU to assess* Correspondence: justin.salciccioli12@imperial.ac.uk
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tice and for research purposes [4-8].
The neutrophil-to-lymphocyte ratio (NLR) is a readily
available biomarker that can be calculated based on a
complete blood count. NLR has previously been shown
to predict outcomes in oncology patients [9] and has
been tested in a number of malignancies, including lung
[10], ovary [11] and breast [12]. Preoperative NLR has
been shown to be prognostic in patients undergoing
colorectal cancer resection [13]. Despite the evidence in
various patient populations demonstrating a relationship
between NLR and mortality, no previous report hasral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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in a large population of unselected critically ill patients.
Our objective in the present study was to evaluate
whether there is an association between NLR and
mortality in a population of adult critically ill patients.
Our primary hypothesis was that NLR at ICU admission
is associated with mortality in critically ill patients. To
test this hypothesis, we performed an observational
study using a large clinical database of unselected adult
critically ill patients.
Material and methods
Data source
We performed an observational study using data col-
lected from the Multiparameter Intelligent Monitoring
in Intensive Care (MIMIC II) open source clinical data-
base. MIMIC II was developed and is maintained by the
Massachusetts Institute of Technology (MIT), Philips
Healthcare and Beth Israel Deaconess Medical Center
(BIDMC) [14]. Patients included in this dataset were
hospitalized between January 2001 and December 2008.
The database includes all physiological data recorded in
the ICU, clinical variables, results of investigations
(including laboratory tests) and survival outcome data.
Survival data are obtained postdischarge from the
Social Security death records.
The MIMIC II database has received ethical approval
from the institutional review boards (IRBs) at BIDMC
and MIT, and, because the database does not contain
protected health information, a waiver of the require-
ment for informed consent was included in the IRB
approval.
Patient population
The criteria for inclusion in this study were that the
patients had to (1) be adults (>17 years of age) at ICU
admission, regardless of admitting diagnosis; and had to
(2) have neutrophil and lymphocyte counts measured at
ICU admission. The exclusion criteria were (1) missing
neutrophil and lymphocyte data at ICU admission, (2)
missing covariate data for multivariable adjustments and
(3) repeat admissions to the ICU. Patients who met the
inclusion criteria and none of the exclusion criteria were
included in the final cohort for investigation.
From each patient record, we extracted the following
available variables from the database at ICU admission:
demographic data, including age in years, sex, comorbid
conditions as coded and defined in the International
Classification of Diseases, Ninth Revision (ICD-9); vital
statistics data and laboratory data; and admission severity
of illness scores (Simplified Acute Physiology Score (SAPS
I) and Sequential Organ Failure Assessment (SOFA)).
SAPS I and SOFA scores were computed automatically in
the database as previously described [15,16].Predictor and outcome variables
The primary exposure of interest was NLR measured at
ICU admission. NLR was computed based on ICU admis-
sion laboratory data as a ratio of neutrophil/lymphocyte
values, which are recorded in the complete blood count,
and patients were categorized by quartile of baseline NLR
value.
The primary outcome was 28-day mortality. Secondary
outcomes were mortality in the ICU, in-hospital mortality
and 1-year mortality. Mortality data were collected from
the Social Security death records.Statistical analysis and modeling strategy
Data for continuous variables are presented as median with
interquartile range (IQR). Dichotomous and categorical
variables are presented as frequencies with percentages. We
assessed the distribution of the primary predictor variable
graphically using histograms. We computed the median
with IQR for the primary predictor variable and categorized
patients according to quartile of baseline NLR at ICU
admission, with the first quartile treated as the reference
group for all subsequent analyses.
The following variables were considered for multivari-
able adjustments: age, sex, baseline laboratory data (white
cell count, neutrophil and lymphocyte data, hemoglobin,
red blood cell count and hematocrit, creatinine and
blood urea nitrogen, and electrolyte data), baseline vital
statistics data (heart rate, respiratory rate, systolic blood
pressure, Glasgow Coma Scale score), comorbid diseases
(congestive heart failure, chronic obstructive pulmonary
disease, cardiac arrhythmia, valvular disease, peripheral
vascular disease, hypertension, hypothyroidism, metastatic
disease or lymphoma, liver failure or renal failure) and
baseline clinical severity markers (SAPS I and SOFA
scores).
We assessed the association of quartile of NLR with
primary and secondary outcomes using univariate logis-
tic regression, and we report the odds ratios (ORs) and
95% confidence intervals (CIs). To assess the association
of quartiles of NLR, we attempted to adjust for potential
confounding with multivariable logistic regression. We
initially included in the multivariable model all variables
with a statistically significant univariate association with
outcome to control for potentially clinically relevant
confounding variables. To avoid overfitting, we manually
removed from the model variables that were not associ-
ated with the outcome and used the Akaike Information
Criterion to define the final model. We report ORs and
95% CIs for the final model. To account for potential
clustering within ICUs, we used a generalized estimating
equation with a variance-covariance structure with com-
pound symmetry. We generated Kaplan-Meier curves to
assess the probability of survival across quartiles of NLR.
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We conducted two confirmatory analyses to further the
primary hypothesis. First, as patients presenting to the
ICU with sepsis are likely to have marked neutrophilia,
which could significantly influence the overall associ-
ation between NLR and outcomes, we planned a priori
to perform a subgroup analysis of patients with sepsis
upon presentation compared with patients without sepsis.
We defined the subgroup of patients with sepsis according
to the criteria outlined by Angus et al. [2]. Patients were
identified by using ICD-9 codes for diagnosis of bacterial
and fungal infectious process as well as for a diagnosis of
acute organ dysfunction as recorded in the MIMIC II
database. Using multivariable regression, we assessed the
relationship between NLR and outcome in the cohorts of
patients with and without sepsis. We also performed a
post hoc test of the sepsis cohort after removing patients
with sepsis who were identified as having neutropenia
(<1.5 × 109 cells/L) at the time of presentation to the ICU.
Second, a number of patients were not included in the
primary analysis because they were missing NLR data at
the time of admission to the ICU. For this reason, we
performed a post hoc sensitivity analysis using the first
neutrophil and lymphocyte data recorded in the ICU.
Whereas patients included in the primary analysis had
NLR data measured upon admission to the ICU, we
assessed the first recorded NLR value in this sensitiv-
ity analysis, regardless of its relation to the time of
admission to the ICU. We repeated the univariate and
multivariable analyses to assess 28-day mortality across
quartiles of NLR, and we report the adjusted ORs and
95% CIs. In addition, to assess the possibility of a selection
bias, we tested, using the χ2 test, the difference in the
crude 28-day survival between patients with and without
NLR measured in the ICU.Reclassification of severity scores
Model discrimination was assessed by calculation of
the receiver operating characteristic (ROC) curves and
report the area under the ROC curve (AUC). In addition
to ROC analysis, we assessed the effect of adding NLR to
risk-adjusted models by using reclassification analytical
methods. As described by Pencina et al. [17,18], reclassifi-
cation analysis is a method that has been recommended
for assessing the incremental contribution of biomarkers
to risk prediction. We calculated the net reclassification
improvement (NRI) index, which is used to measure the
ability of a new model (with the new biomarker, in this
case NLR) to reclassify a high-risk individual as higher risk
and a low-risk individual as lower risk. We also assessed
the integrated discrimination improvement (IDI) index,
which takes into account the overall joint improvement in
calculating the sensitivity and specificity of the new model.All reported tests of the data are two-sided with a
significance level of 5%, and CIs are reported as two-sided
95% CIs. Statistical tests of the data were performed in
SAS v9.3 software (SAS Institute, Cary, NC, USA) as well
as in R v3.0.1 (R Foundation for Statistical Computing,
Vienna, Austria).
Results
Population characteristics
There were a total of 5,763 patients with complete neu-
trophil and lymphocyte data available upon admission,
and all of these patients had complete data available for
the primary outcome. After excluding patients with
missing data from any of the selected covariates, 5,056
patients made up the final cohort for analysis.
The median age of the cohort was 65 years (IQR, 51
to 78), and 47% of patients were female. The median
SAPS I score was 14 (IQR, 10 to 18), and the median
SOFA score was 6 (IQR, 3 to 9). The majority (54%) of
the patients were admitted to the ICU from the emer-
gency department setting, with 56% of patients treated
as medical inpatients, 20% as surgical admissions and an
additional 18% treated in the cardiac care unit. Additional
baseline characteristics of the study population are shown
in Table 1.
The median NLR for the entire cohort was 8.9 (IQR,
4.99 to 16.21). Selected hematologic laboratory data
across quartiles of NLR are provided in Table 2. A total
of 966 (19%) of the patients died by 28 days, the primary
outcome in this study. The overall in-hospital mortality
rate was 17%, and 31% of patients had died at 1-year
following ICU admission.
Association of neutrophil-to-lymphocyte ratio with
primary and secondary outcomes
There was a statistically significant stepwise increase in
crude mortality rate with increasing quartile of baseline
NLR. The crude mortality rates by increasing quartile of
NLR were as follows: first quartile = 159 (13%), second
quartile = 199 (16%), third quartile = 254 (20%) and fourth
quartile 354 (28%) (P < 0.001). In unadjusted analysis,
we found a statistically significant relationship between
increasing quartile of NLR and 28-day mortality. This
stepwise increase in risk of death remained statistically
significant after multivariable adjustments, and similar
trends in mortality were present for all secondary outcomes
tested (Figures 1 and 2, respectively). The relationship
between NLR and 1-year mortality is shown in the
Kaplan-Meier curves in Figure 3.
Subset and sensitivity analyses
Compared with patients without sepsis (n = 3,224),
patients admitted to the ICU with sepsis (n = 1,832) had
a statistically significantly higher baseline NLR value at
Table 1 Baseline characteristics of the study populationa
Parameter Total cohort (N = 5,056) Sepsis subgroup (n = 1,832)
Age, yr 65 (51 to 78) 69 (55 to 80)
Female sex, n (%) 2,377 (47) 879 (48)
Care unit, n (%)
Cardiac intensive care unit 1,264 (25) 384 (21)
Cardiac surgical intensive care unit 1,154 (23) 427 (23)
Medical intensive care unit 2,361 (47) 979 (53)
Surgical intensive care unit 227 (6) 42 (2)
Comorbid conditions, n (%)
Congestive heart failure 1,254 (25) 651 (36)
Chronic obstructive pulmonary disease 953 (19) 343 (19)
Diabetes 1,167 (23) 474 (26)
Hypertension 1,518 (30) 499 (27)
Mechanical ventilation (first 24 hr), n (%) 2,343 (46) 934 (51)
Vasopressor use (first 24 hr), n (%) 1,397 (28) 756 (41)
Glasgow Coma Scale score (IQR) 14 (8 to 15) 14 (8 to 15)
Simplified Acute Physiology Score I (IQR) 14 (10 to 18) 16 (12 to 20)
Sequential Organ Failure Assessment score (IQR) 6 (3 to 9) 8 (4 to 11)
aData are median and interquartile range (IQR) or number and percentage.
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4.6 to 14.3); P < 0.001). For patients without sepsis, there
was a statistically significant stepwise increase in the risk
of death at 28 days with increasing quartile of NLR in
both univariate and multivariable analyses (adjusted ORs:
first quartile = reference value; second quartile = 1.18
(95% CI, 0.81 to 1.72; P = 0.4); third quartile = 1.69 (95%
CI, 1.20 to 2.40); P = 0.003); fourth quartile = 2.13 (95%
CI, 1.52 to 2.99); P < 0.001). In patients who met the sepsis
criteria at ICU admission, there was no relationship
between NLR and 28-day mortality (adjusted ORs: first
quartile = reference value; second quartile = 1.11 (95% CI,
0.79 to 1.57); third quartile = 0.92 (95% CI, 0.66 to 1.30);
fourth quartile = 1.23 (95% CI, 0.86 to 1.70); all P > 0.05).
After removing the patients with sepsis and neutropenia,
there was no relationship between NLR and 28-day
mortality (adjusted ORs: first quartile = reference value;Table 2 Laboratory data across quartiles of neutrophil-to-lym
Neutrophil-to-lymphocyte r
Parameter First quartile S
(<4.99) (4
White blood cell count, ×109 cells/L 8.4 (5.6 to 11.4) 1
Red blood cell count, ×1012 cells/L 3.64 (3.11 to 4.22) 3
Hematocrit, % 32.5 (28.1 to 37.4) 3
Hemoglobin, g/dl 11.0 (9.5 to 12.9) 1
Mean red cell volume, fl 90.0 (86.0 to 94.0) 8
Red cell distribution width 14.4 (13.5 to 15.9) 1second quartile = 1.23 (95% CI, 0.86 to 1.74); third
quartile = 1.04 (95% CI, 0.73 to 1.47); fourth quartile = 1.32
(95% CI, 0.94 to 1.85); all P > 0.05).
A total of 1,942 patients who did not have baseline
NLR values were assessed in the post hoc analysis of the
first measured NLR values and outcomes. The crude
mortality rate across quartiles of NLR were as follows:
first quartile = 13%, second quartile = 21%, third quar-
tile = 21%, fourth quartile = 30% (P < 0.001). After mul-
tivariable adjustments, there was a significant trend for
increasing mortality with increasing quartile of NLR;
however, this did not follow a stepwise pattern as it did
in the primary analysis (adjusted ORs: first quartile =
reference value; second quartile = 1.55 (95% CI, 1.08 to
2.23), P = 0.02); third quartile = 1.30 (95% CI, 0.90
to 1.86), P = 0.2); fourth quartile = 1.99 (95% CI, 1.41
to 2.82), P < 0.001).phocyte ratio
atio quartile (range)
econd quartile Third quartile Fourth quartile
.99 to 8.90) (8. 90 to 16.21) (>16.21)
1.3 (8.7 to 14.7) 13.4 (10.0 to 18.1) 16.2 (11.6 to 22.1)
.72 (3.25 to 4.25) 3.69 (3.27 to 4.21) 3.69 (3.25 to 4.17)
3.1 (28.8 to 37.7) 33.0 (29.3 to 37.2) 33.1 (29.1 to 37.1)
1.2 (9.7 to 12.8) 11.1 (9.8 to 12.6) 11.0 (9.8 to 12.5)
9.0 (85.0 to 93.0) 89.0 (85.0 to 93.0) 90.0 (86.0 to 94.0)
4.4 (13.4 to 15.9) 14.4 (13.5 to 15.9) 14.8 (13.7 to 16.3)
Figure 1 Twenty-eight-day mortality rates across quartiles of neutrophil-to-lymphocyte ratio (unadjusted and adjusted results). Crude
mortality rates with percentages for patients whose neutrophil-to-lymphocyte ratio (NLR) was measured at the time of admission to the ICU
shows a stepwise increase in mortality with increasing quartile of NLR (first quartile = 13%, second quartile = 16%, third quartile = 20%, fourth
quartile = 28%). Results of unadjusted and adjusted analyses for quartile of NLR and mortality with Odds Ratios (ORs) and 95% Confidence
Intervals (CIs) are also provided. First Quartile < 4.99, second Quartile = 4.99 – 8.90, third Quartile = 8.90 – 16.21, fourth Quartile > 16.21.
Quartile Number (%) 
Intensive Care 
Unit Mortality P-Value 
Number 
(%) 
In-Hospital 
Mortality P-Value 
Number 
(%) 
1-Year 
Mortality P-Value 
1 99 (8) Ref. Ref.  150 (12) Ref. Ref.  290 (23) Ref. Ref. 
2 119 (9) 1.40 (1.01 – 1.93) 0.04  174 (14) 1.25 (0.95 – 1.63) 0.1  343 (27) 1.19 (0.97 – 1.46) 0.1 
3 148 (12) 1.35 (0.99 – 1.85) 0.05  227 (18) 1.36 (1.05 – 1.75) 0.02  433 (34) 1.40 (1.14 – 1.71) 0.001 
4 230 (18) 1.72 (1.28 – 2.31) < 0.001  318 (25) 1.58 (1.23 – 2.02) < 0.001  523 (41) 1.45 (1.19 – 1.77) < 0.001 
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Figure 2 Multivariable analysis of secondary outcomes. After multivariable adjustments, we found a stepwise increase in mortality across all
secondary outcomes, including intensive care unit (ICU) mortality (A), in-hospital mortality (B) and 1-year mortality (C). Point estimates represent
the odds ratios (ORs), and error bars represent the 95% confidence intervals (CIs). Numeric ORs and 95% CIs are provided for each of the secondary
outcomes. NLR, Neutrophil-to-lymphocyte ratio.
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Figure 3 Kaplan-Meier survival analysis plot for 1-year mortality with quartiles of neutrophil-to-lymphocyte ratio. The curves demonstrate
that patients can be stratified for long-term survival on the basis of neutrophil-to-lymphocyte ratio (NLR) at the time of presentation to the intensive
care unit. Patients in the first NLR quartile had the highest probability of survival at 1 year, and patients in the fourth NLR quartile had the lowest
probability of survival at 1 year.
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and reclassification
When we took into consideration the primary outcome
of 28-day mortality in the entire study cohort, the
addition of NLR to SAPS I score improved the AUC
from 0.746 to 0.757 (P < 0.001). Reclassification statistics
showed a significant improvement in NRI index of 0.032
(P < 0.001), indicating that, on average, 3.2% of patients
had their 28-day mortality predictions from SAPS I
score accurately reclassified with the addition of NLR.
Similarly, the IDI index was 0.008 (P < 0.001), indicating
that an aggregate measure of sensitivity and specificity
was superior for SAPS I score and NLR compared with
SAPS I score only. The results for the nonseptic and
septic cohorts were similar (Additional file 1: Table S1).
Discussion
We found that the NLR measured at the time of admission
to ICU was associated with 28-day mortality in a popula-
tion of unselected critically ill patients. NLR was able to
accurately stratify patients in terms of both short-term and
long-term mortality. Whereas NLR remained statistically
significantly associated with outcomes in patients without
sepsis, there was no relationship between NLR and out-
comes in patients with sepsis. These findings remained
robust after adjustment for multiple potential confounding
variables, suggesting that NLR may be independently asso-
ciated with outcomes in critical illness.
The hypothesis that NLR is associated with outcomes
is based primarily on the physiological link between neu-
trophilia and lymphopenia with systemic inflammation
and stress. First reported by Zahorec et al. [9], the NLRmay be indicative of the patient’s response to inflamma-
tory insult, with neutrophils rising in response to stress,
which, when overwhelming, induces lymphocyte apoptosis
[19-21]. For example, Heffernan et al. identified the pres-
ence of concurrent lymphopenia and neutrophilia in
trauma patients and patients who met the criteria for the
systemic inflammatory response syndrome [22]. Lympho-
cytes are important for the regulation of an appropriate
inflammatory response, and their loss due to apoptosis,
cellular exhaustion and downregulation may perpetuate a
detrimental inflammatory state [22,23]. Taken together,
the resulting increase in NLR may identify patients who
have less physiological reserve to survive the inflammatory
insult and concomitant decreased survival rates.
Previous reports have highlighted the association between
increased NLR and worse outcomes in patients with cancer
of the pancreas [24,25], breast [12], lung [10] and colon
[13]. In addition to cohorts of oncology patients, in a
prospective study, Suliman et al. found that a higher NLR
was associated with higher rates of mortality in patients
admitted with acute coronary syndrome [26]. NLR has
been investigated for its association with adverse outcomes
in acute pancreatitis and has been identified as a significant
predictor of ICU admission and a longer stay [27]. These
data suggest that NLR is important in multiple patient
populations and further support our hypothesis that NLR
reflects the severity of the underlying systemic dis-
turbance. Compared with other investigations of NLR in
non-critically ill populations, our investigation revealed a
significantly higher median NLR. This is consistent with
the proposed mechanism of NLR representing elevated sys-
temic inflammation and severity of illness seen in the ICU.
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in patients with sepsis as a subgroup because immune
dysregulation is intrinsic to the disease process. Although
we found an association between NLR and outcome in the
nonseptic cohort, there was no relationship between NLR
and outcome in the subgroup of patients with sepsis at
the time of admission to the ICU. These findings are in
contrast to those of a previous study of NLR tested in a
population of oncology patients with sepsis [9] and pre-
vious findings that have demonstrated an association
between lymphopenia and the sepsis syndrome [28].
Additionally, previous studies have demonstrated an
association between neutrophilia and mortality in patients
with sepsis [29,30]. In contrast, Bermejo-Martín et al.
found an association between low circulating neutrophil
count and mortality [31]. It is hypothesized that patients
with sepsis who have low circulating neutrophil counts
may have difficulty mounting an appropriate innate im-
mune response. In addition, the sepsis syndrome may
increase neutrophil adhesion to the vascular endothelium
(and a resultant decrease in measured levels of circulating
neutrophils), causing endothelial damage, a common
complication of the sepsis syndrome [31]. Further, it is
possible that neutrophils can exist in the circulation in
varying functional states, and a cross-sectional assessment
(as in the present study) relating to the neutrophil or
lymphocyte count may be inadequate to understand the
effect of these parameters on diseases such as the sepsis
syndrome that last days to weeks [32].
The strengths of this study include a large population
size and an unselected group of patients, which provided
increased generalizability in ICU patients and external
validity of our findings in the critical care setting. We
were able to use a large clinical dataset with a number
of measured characteristics controlled for with multi-
variable modeling. Furthermore, although our study
was designed to assess NLR in a population of unse-
lected critically ill patients, we planned a priori to test
any difference in the relationship between patients with
and without sepsis. This sensitivity analysis was planned
in advance, as the pathophysiology of the sepsis response
in the critical care setting varies widely, and it is likely
that patients with sepsis are inherently different from
other critically ill patient populations. Given the results
of this sensitivity analysis, it is important for future
investigations of NLR in critically ill populations to
consider and assess accordingly any differences between
patient subpopulations.
This study has a number of limitations that should be
taken into consideration when interpreting the results.
We conducted a single-center observational study, and
thus, as with any observational study, the potential remains
for residual confounding. Further associations identified
are dependent upon covariates in the model, and othervariables not recorded in the database may affect the re-
sults if included in an alternative model. We assessed the
difference in association between NLR and outcomes in
patients who presented to the ICU with sepsis compared
with those without sepsis and categorized patients using
the Angus et al. criteria [2]. However, sepsis is inherently
difficult to classify, and misclassification could have in-
appropriately shifted our results away from or toward the
null set.
In addition, we attempted to assess the incremental
effect of adding NLR to an existing severity of illness
scoring system (SAPS I). However, additional severity of
illness scores have been derived since the development
of SAPS I, and this may limit our conclusion about the
incremental improvement of NLR over existing severity
of illness scores. A number of patients in this investigation
did not have their neutrophil or lymphocyte data recorded,
and we are unable to assess the reason for this using this
dataset. It is possible that these data were reported only at
the request of the treating clinical team and therefore that
an additional selection bias may have been introduced into
the current analysis. In future investigations that are
designed prospectively to measure NLR data of sequential
patients, researchers may be better able to assess the utility
of reporting neutrophil and lymphocyte data on all patients
presenting to the ICU.
Conclusions
The NLR measured upon admission to the ICU was asso-
ciated with both short- and long-term mortality in adult
critically ill patients. This relationship was strongest in
patients without sepsis. NLR may be a useful indicator of
the inflammatory response in adult critical illness. The
mechanisms underlying these associations are yet to be
fully elucidated and should be the focus of future pro-
spective clinical research.
Key messages
 NLR was associated with outcomes in various
populations and may represent underlying
inflammation.
 NLR was associated with mortality in a cohort of
adult critically ill patients.
 The relationship between NLR and mortality was
strongest in patients who did not have evidence of
sepsis.
 These findings should be validated prospectively in
further research.
Additional file
Additional file 1: Table S1. Results of reclassification indices for NLR
with SAPS-I scoring.
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